HPCM
MDT icon

Hunter Perkins Capital Management’s Medtronic MDT Stock Holding History

Hunter Perkins Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,000
Closed -$469K – 137
2020
Q4 		$469K Buy
+4,000
New +$440K 0.08% 123

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hunter Perkins Capital Management's MDT Position: Q1 2021 in Review

Hunter Perkins Capital Management sold out of Medtronic (MDT) in Q1 2021, closing a stake of 4,000 shares — an estimated $469K sold.

Hunter Perkins Capital Management first reported a position in MDT in Q4 2020 and held it in 1 quarter. The position peaked at $469K in Q4 2020. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

  • Hunter Perkins Capital Management reported no remaining Medtronic position as of Q1 2021 after selling out during the quarter.
  • Hunter Perkins Capital Management sold 4,000 Medtronic shares in Q1 2021, an estimated $469K.
  • Hunter Perkins Capital Management first reported a position in Medtronic in Q4 2020 and held it in 1 quarter.
  • Hunter Perkins Capital Management's Medtronic position peaked at $469K in Q4 2020.
  • 1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on Hunter Perkins Capital Management's 13F filing for Q1 2021, filed 28 Apr 2021.